Assay News and Research

RSS

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

Study shows an inflammatory response in the mice brain is responsible for severe COVID-19

Researchers demonstrated that neuroinvasion and encephalitis caused by SARS-CoV-2 is associated with significant mortality in a special mouse model.

17 Dec 2020

Potency of neutralizing antibodies predicts COVID-19 severity and survival

Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.

16 Dec 2020

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

For over ten years, Ali Yanik has been working to develop novel biosensor technology to provide rapid, low-cost testing for disease diagnostics and precision medicine.

16 Dec 2020

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses?

16 Dec 2020

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

The second wave of COVID-19 has affected many countries, costing thousands of lives and dealing further heavy blows to already reeling economies.

16 Dec 2020

Reliable Antibodies Testing for SARS-CoV-2

In this interview, Poncho Meisenheimer, VP of R&D at Promega, talks to News-Medical Life Sciences about the importance of having the reliability for SARS-Co-V-2 antibody tests.

From Promega Corporation 15 Dec 2020

EUROIMMUN receives CE mark for new PCR test to differentiate between COVID-19 and flu

EUROIMMUN today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of viruses.

From Revvity 15 Dec 2020

World Health Organization issues notice for in vitro diagnostics users

Nucleic acid testing (NAT) technologies that use real-time polymerase chain reaction (RT-PCR) for detection of SARS-CoV-2.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

A new study published in the pre-print server bioRxiv* explores the viral enzyme PLpro, encoded in the nonstructural protein nsp3, and its inhibitors. T

14 Dec 2020

WVU, DHHR team up to create new COVID-19 testing laboratory in Morgantown

To address the challenges of COVID-19 testing shortages and lagging turnaround times, West Virginia University and the West Virginia Department of Health and Human Resources have teamed up to create a new testing laboratory at the Health Sciences Center thanks to funding made possible by Gov. Jim Justice.

11 Dec 2020

Saliva-based smartphone COVID-19 testing platform provides results within 15 minutes

Offering an ultrasensitive yet accessible approach to COVID-19 testing, a portable saliva-based smartphone platform provides results within 15 minutes without the resource-intensive laboratory tests the current gold standard requires, according to a new study.

11 Dec 2020

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and Technology have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA).

11 Dec 2020

Researchers use AI platform to identify best combination of available therapies against COVID-19.

A team of researchers from the National University of Singapore (NUS) has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

11 Dec 2020

Using AI to find optimal combination of available therapies against SARS-CoV-2

A team of researchers from the National University of Singapore has utilized a ground-breaking artificial intelligence (AI) platform to derive an optimal combination of available therapies against SARS-CoV-2, the cause of COVID-19.

10 Dec 2020

MEDS433 hinders SARS-CoV-2 replication

A paper that recently appeared in the preprint server bioRxiv* reports the powerful activity of a compound named MEDS433 against this virus.

10 Dec 2020

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.

10 Dec 2020

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 10 Dec 2020

Organic hydrogels can be a promising candidate for building long-term functioning glucose biosensors

In a new study, published online in the journal American Chemical Society (ACS) Applied Polymer Materials, scientists at Texas A&M University reported they have designed a hydrogel membrane that may be used to house optical glucose sensing materials, toward building a biosensor for monitoring sugar levels in diabetics.

10 Dec 2020

Assay News and Research

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Study shows an inflammatory response in the mice brain is responsible for severe COVID-19

Potency of neutralizing antibodies predicts COVID-19 severity and survival

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Reliable Antibodies Testing for SARS-CoV-2

EUROIMMUN receives CE mark for new PCR test to differentiate between COVID-19 and flu

World Health Organization issues notice for in vitro diagnostics users

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

WVU, DHHR team up to create new COVID-19 testing laboratory in Morgantown

Saliva-based smartphone COVID-19 testing platform provides results within 15 minutes

Rapid lateral flow immunoassay enables fluorescence detection of SARS-Cov-2 RNA

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

MEDS433 hinders SARS-CoV-2 replication

Researchers develop new serological assay for detection of SARS-CoV-2 antibodies

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

Organic hydrogels can be a promising candidate for building long-term functioning glucose biosensors

Measuring Drug-Target Residence Times with Biochemical Assays eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News